High-resolution metabolomics determines the mode of onset of type 2 diabetes in a 3-year prospective cohort study
- Authors
- Lee, Yeseung; Pamungkas, Aryo Dimas; Medriano, Carl Angelo D.; Park, Jinsung; Hong, Seri; Jee, Sun Ha; Park, Youngja H.
- Issue Date
- 2월-2018
- Publisher
- SPANDIDOS PUBL LTD
- Keywords
- liquid chromatography-mass spectrometry; type 2 diabetes; metabolomics; cholesterol
- Citation
- INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, v.41, no.2, pp.1069 - 1077
- Indexed
- SCIE
SCOPUS
- Journal Title
- INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Volume
- 41
- Number
- 2
- Start Page
- 1069
- End Page
- 1077
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/77809
- DOI
- 10.3892/ijmm.2017.3275
- ISSN
- 1107-3756
- Abstract
- Type 2 diabetes mellitus (DM) is a progressive disease and the rate of progression from non-diabetes to DM varies considerably between individuals, ranging from a few months to many years. It is important to understand the mechanisms underlying the progression of diabetes. In the present study, a high-resolution metabolomics (HRM) analysis was performed to detect potential biomarkers and pathways regulating the mode of onset by comparing subjects who developed and did not develop type 2 DM at the second year in a 3-year prospective cohort study. Metabolic profiles correlated with progression to DM were examined. The subjects (n=98) were classified into four groups: Control (did not develop DM for 3 years), DM (diagnosed with DM at the start of the study), DM onset at the third year and DM onset at the second year. The focus was on the comparison of serum samples of the DM groups with onset at the second and third year from the first year, where these two groups had not developed DM, yet. Analyses involved sample examination using liquid chromatography-mass spectrometry-based HRM and multivariate statistical analysis of the data. Metabolic differences were identified across all analyses with the affected pathways involved in metabolism associated with steroid biosynthesis and bile acid biosynthesis. In the first year, higher levels of cholesterol {mass-to charge ratio (m/z) 369.35, (M+H-H2O)(+)}, 25-hydroxycholesterol [m/z 403.36, (M+H)(+)], 3,7-dihydroxy-5 beta-cholestane [m/z 443.33, (M+K)(+)], 4 alpha-methylzymosterol-4-carboxylate [m/z 425.34, (M+H-H2O)(+)], and lower levels of 24,25-dihydrolanosterol [m/z 429.40, (M+H)(+)] were evident in the group with DM onset at the second year compared with those in the group with DM onset at the third year. These results, with a focus on the cholesterol biosynthesis pathway, point to important aspects in the development of DM and may aid in the development of more effective means of treatment and prevention.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Control and Instrumentation Engineering > 1. Journal Articles
- College of Pharmacy > Department of Pharmaceutical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.